QualityStocks would like to highlight HST Global, Inc. (OTCBB: HSTC). The company is an Integrated Biotechnology Health and Wellness company that is developing and or acquiring a network of Wellness Centers worldwide that are primarily focused on the homeopathic and alternative treatment of late stage cancer. In addition, the company intends to acquire innovative products for the treatment of late stage cancer. In this regard, the company primarily focuses on homeopathic and alternative product candidates that are undergoing or have already completed significant clinical testing for the treatment of late stage cancer.
In the company’s news yesterday,
HST Global, Inc. announced that it has commenced a project with EBITDA Capital, LLC for both shareholder participation and health and wellness center operations within Saudi Arabia.
EBITDA Capital, LLC will begin working with their contacts and clients within the Kingdom of Saudi Arabia. Key clientele within the Royal Family have shown interest in becoming shareholders in HSTC. They are also interested in operating a health and wellness clinic based within the Gulf Cooperation Council Countries (GCC). If one (or several) were to be built, they would include both for-profit and non-profit treatment facilities in support of HSTC’s late stage cancer applications. The company would be responsible for the training, maintenance and management development in these clinics.
Mr. Chet Noblett, Managing General Partner of EBITDA, is facilitating the initial negotiations and is leveraging his long term relationships with these parties. Mr. Noblett stated, “We have been cautiously opening the window of opportunity for HSTC with our associates in Saudi Arabia. Health care is a top priority throughout the GCC and HSTC offers the opportunity to energize the effort by establishing these clinics. We are very pleased to have the level of interest and acceptance that has been expressed at this time.”
Ron Howell, President and CEO of HST Global, Inc., commented, “The commencement of this initiative within the GCC Countries characterizes the essence of what HSTC is developing. The combined capital and strategic operational partnership will bring an affordable, yet cost effective treatment for late stage cancer to the GCC. HSTC is reaching across the Globe with its brand of alternative health and wellness centers.”
HSTC also told investors that it has plans to establish clinics modeled after the GCC project within a number of Asian markets where EBITDA has already made initial contacts.
About QualityStocks
QualityStocks, based in Scottsdale, Arizona is a free service that collects data from hundreds Small-Cap and Micro-Cap online Investment Newsletters into one Free Daily Newsletter Report. QualityStocks is dedicated to assisting emerging public companies with their advertising efforts and now has over 500,000+ subscribers that receive The Daily Stock Newsletters.
Please see disclaimer on QualityStocks website: http://Disclaimer.QualityStocks.net
Forward-Looking Statement:
This release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. Risks and uncertainties applicable to the company and its business could cause the company's actual results to differ materially from those indicated in any forward-looking statements.
